GSDME and small cell lung carcinoma: For SCLC patients receiving chemo-immunotherapy, the expression of GSDME protein was positively correlated with longer chemotherapy PFS (y = 3.2745x+188.41, R 2 = 0.3071, two-tailed P < 0.01) (Supplementary Figure 1D).